vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Star Equity Holdings, Inc. (STRR). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $56.8M, roughly 1.3× Star Equity Holdings, Inc.). On growth, Star Equity Holdings, Inc. posted the faster year-over-year revenue change (69.0% vs 27.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-9.0M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 29.5%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

Artists Equity is an American production company founded by actors and filmmakers Ben Affleck and Matt Damon in November 2022.

PBYI vs STRR — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.3× larger
PBYI
$75.5M
$56.8M
STRR
Growing faster (revenue YoY)
STRR
STRR
+41.3% gap
STRR
69.0%
27.7%
PBYI
More free cash flow
PBYI
PBYI
$23.3M more FCF
PBYI
$14.4M
$-9.0M
STRR
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
29.5%
STRR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
STRR
STRR
Revenue
$75.5M
$56.8M
Net Profit
$-1.7M
Gross Margin
69.3%
Operating Margin
22.7%
-0.2%
Net Margin
-3.0%
Revenue YoY
27.7%
69.0%
Net Profit YoY
-192.1%
EPS (diluted)
$0.26
$-0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
STRR
STRR
Q4 25
$75.5M
$56.8M
Q3 25
$54.5M
$48.0M
Q2 25
$52.4M
$35.5M
Q1 25
$46.0M
$31.9M
Q4 24
$59.1M
$33.6M
Q3 24
$80.5M
$36.9M
Q2 24
$47.1M
$35.7M
Q1 24
$43.8M
$33.9M
Net Profit
PBYI
PBYI
STRR
STRR
Q4 25
$-1.7M
Q3 25
$8.8M
$-1.8M
Q2 25
$5.9M
$-688.0K
Q1 25
$3.0M
$-1.8M
Q4 24
$-585.0K
Q3 24
$20.3M
$-846.0K
Q2 24
$-4.5M
$-441.0K
Q1 24
$-4.8M
$-2.9M
Gross Margin
PBYI
PBYI
STRR
STRR
Q4 25
69.3%
Q3 25
77.7%
43.0%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
50.5%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
PBYI
PBYI
STRR
STRR
Q4 25
22.7%
-0.2%
Q3 25
17.6%
-3.4%
Q2 25
12.7%
-0.6%
Q1 25
8.7%
-5.4%
Q4 24
22.6%
-0.4%
Q3 24
27.4%
-1.2%
Q2 24
-4.6%
-0.5%
Q1 24
-5.3%
-9.0%
Net Margin
PBYI
PBYI
STRR
STRR
Q4 25
-3.0%
Q3 25
16.2%
-3.7%
Q2 25
11.2%
-1.9%
Q1 25
6.5%
-5.5%
Q4 24
-1.7%
Q3 24
25.2%
-2.3%
Q2 24
-9.6%
-1.2%
Q1 24
-11.0%
-8.6%
EPS (diluted)
PBYI
PBYI
STRR
STRR
Q4 25
$0.26
$-0.49
Q3 25
$0.17
$-0.54
Q2 25
$0.12
$-0.23
Q1 25
$0.06
$-0.59
Q4 24
$0.40
$-0.21
Q3 24
$0.41
$-0.28
Q2 24
$-0.09
$-0.15
Q1 24
$-0.10
$-0.95

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
STRR
STRR
Cash + ST InvestmentsLiquidity on hand
$97.5M
$10.3M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$65.7M
Total Assets
$216.3M
$113.2M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
STRR
STRR
Q4 25
$97.5M
$10.3M
Q3 25
$94.4M
$15.4M
Q2 25
$96.0M
$16.8M
Q1 25
$93.2M
$16.6M
Q4 24
$101.0M
$17.0M
Q3 24
$96.7M
$15.8M
Q2 24
$96.8M
$14.7M
Q1 24
$107.2M
$20.4M
Total Debt
PBYI
PBYI
STRR
STRR
Q4 25
$22.7M
Q3 25
$34.0M
$6.5M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
$0
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
STRR
STRR
Q4 25
$130.3M
$65.7M
Q3 25
$115.3M
$67.8M
Q2 25
$104.7M
$40.1M
Q1 25
$97.1M
$39.5M
Q4 24
$92.1M
$40.4M
Q3 24
$71.1M
$42.9M
Q2 24
$48.5M
$42.6M
Q1 24
$51.0M
$44.3M
Total Assets
PBYI
PBYI
STRR
STRR
Q4 25
$216.3M
$113.2M
Q3 25
$202.9M
$117.1M
Q2 25
$194.9M
$55.6M
Q1 25
$196.2M
$53.2M
Q4 24
$213.3M
$52.6M
Q3 24
$220.7M
$52.6M
Q2 24
$205.0M
$52.6M
Q1 24
$214.1M
$52.6M
Debt / Equity
PBYI
PBYI
STRR
STRR
Q4 25
0.17×
Q3 25
0.30×
0.10×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
0.00×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
STRR
STRR
Operating Cash FlowLast quarter
$14.4M
$-7.3M
Free Cash FlowOCF − Capex
$14.4M
$-9.0M
FCF MarginFCF / Revenue
19.1%
-15.8%
Capex IntensityCapex / Revenue
0.0%
3.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$41.7M
$-13.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
STRR
STRR
Q4 25
$14.4M
$-7.3M
Q3 25
$9.7M
$-2.7M
Q2 25
$14.1M
$139.0K
Q1 25
$3.6M
$-802.0K
Q4 24
$15.6M
$-2.8M
Q3 24
$11.0M
$1.3M
Q2 24
$1.0M
$-4.3M
Q1 24
$11.2M
$-1.8M
Free Cash Flow
PBYI
PBYI
STRR
STRR
Q4 25
$14.4M
$-9.0M
Q3 25
$9.7M
$-3.4M
Q2 25
$14.1M
$102.0K
Q1 25
$3.6M
$-808.0K
Q4 24
$15.6M
$-2.8M
Q3 24
$11.0M
$1.3M
Q2 24
$1.0M
$-4.3M
Q1 24
$-1.8M
FCF Margin
PBYI
PBYI
STRR
STRR
Q4 25
19.1%
-15.8%
Q3 25
17.7%
-7.0%
Q2 25
26.8%
0.3%
Q1 25
7.7%
-2.5%
Q4 24
26.4%
-8.3%
Q3 24
13.7%
3.4%
Q2 24
2.1%
-12.0%
Q1 24
-5.3%
Capex Intensity
PBYI
PBYI
STRR
STRR
Q4 25
0.0%
3.0%
Q3 25
0.0%
1.3%
Q2 25
0.0%
0.1%
Q1 25
0.1%
0.0%
Q4 24
0.0%
0.1%
Q3 24
0.0%
0.0%
Q2 24
0.0%
0.0%
Q1 24
0.0%
0.0%
Cash Conversion
PBYI
PBYI
STRR
STRR
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PBYI
PBYI

Segment breakdown not available.

STRR
STRR

Revenue From Other Contracts With Customers$27.6M49%
Other$24.3M43%
Energy Services Segment$4.9M9%

Related Comparisons